First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 2.9 GBX Market Closed
Updated: Jul 12, 2024
Have any thoughts about
Fusion Antibodies PLC?
Write Note

Income Statement

Earnings Waterfall
Fusion Antibodies PLC

Revenue
1.6m GBP
Cost of Revenue
-1.7m GBP
Gross Profit
-117k GBP
Operating Expenses
-2.9m GBP
Operating Income
-3m GBP
Other Expenses
184k GBP
Net Income
-2.8m GBP

Income Statement
Fusion Antibodies PLC

Rotate your device to view
Income Statement
Currency: GBP
Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023
Revenue
Revenue
3
N/A
2
-28%
2
+13%
3
+50%
4
+19%
4
+4%
4
+3%
5
+13%
5
+2%
4
-12%
3
-31%
2
-46%
Gross Profit
Cost of Revenue
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
Gross Profit
1
N/A
1
-47%
1
+3%
1
+78%
2
+24%
2
+8%
2
+6%
2
+16%
2
+5%
2
-24%
1
-69%
(0)
N/A
Operating Income
Operating Expenses
(1)
(2)
(2)
(3)
(3)
(3)
(3)
(4)
(4)
(4)
(3)
(3)
Selling, General & Administrative
(1)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
Research & Development
0
0
0
0
0
(0)
(1)
(1)
(1)
(1)
(1)
(1)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
(0)
0
0
Operating Income
0
N/A
(1)
N/A
(2)
-4%
(1)
+18%
(1)
+14%
(1)
+5%
(1)
-24%
(1)
-7%
(1)
+1%
(2)
-46%
(3)
-48%
(3)
-6%
Pre-Tax Income
Interest Income Expense
(0)
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
Non-Reccuring Items
(1)
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(1)
N/A
(1)
-104%
(1)
-4%
(1)
+18%
(1)
+13%
(1)
+5%
(1)
-23%
(1)
-6%
(1)
+1%
(2)
-46%
(3)
-47%
(3)
-6%
Net Income
Tax Provision
0
0
0
0
0
0
(2)
(2)
0
0
0
0
Income from Continuing Operations
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(2)
(3)
(3)
Net Income (Common)
(1)
N/A
(1)
-82%
(1)
+1%
(1)
+21%
(1)
+30%
(1)
+0%
(3)
-317%
(3)
-4%
(1)
+60%
(2)
-44%
(3)
-50%
(3)
-9%
EPS (Diluted)
-0.04
N/A
-0.05
-25%
-0.06
-20%
-0.05
+17%
-0.03
+40%
-0.03
N/A
-0.11
-267%
-0.12
-9%
-0.05
+58%
-0.07
-40%
-0.1
-43%
-0.06
+40%

See Also

Discover More